Orbimed Advisors - ERASCA INC ownership

ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 88 filers reported holding ERASCA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ERASCA INC
ValueSharesWeighting
Q2 2022$9,289,000
-35.2%
1,667,6930.0%0.17%
-27.9%
Q1 2022$14,342,000
-44.8%
1,667,6930.0%0.23%
-30.2%
Q4 2021$25,983,000
-43.5%
1,667,693
-23.1%
0.33%
-33.9%
Q3 2021$45,991,0002,167,3410.50%
Other shareholders
ERASCA INC shareholders Q3 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 11,055,554$21,779,44114.15%
EDBI Pte Ltd 888,888$1,751,1091.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,926,000$3,794,2201.28%
Cormorant Asset Management, LP 10,813,246$21,302,0951.24%
AH Equity Partners LSV II, L.L.C. 312,500$615,6250.64%
Artal Group S.A. 4,721,194$9,3010.40%
PFM Health Sciences, LP 3,930,633$7,743,3470.36%
ARMISTICE CAPITAL, LLC 8,356,000$16,461,3200.25%
SANDERS MORRIS HARRIS LLC 425,297$816,5690.17%
Prosight Management, LP 264,710$521,4790.16%
View complete list of ERASCA INC shareholders